Recro Pharma – $15 Million Follow-On

New York – August 30, 2016 – Cooley advised the underwriters on Recro Pharma's $14.9 million follow-on offering of 1,986,666 shares of common stock.

Recro Pharma, which trades on The NASDAQ Capital Market as "REPH," is a specialty pharmaceutical company focused on products for hospitals and ambulatory care settings that is currently developing non-opioid products for the treatment of acute pain.

Piper Jaffray & Co. acted as sole book-running manager for the offering and Janney Montgomery Scott acted as co-manager.

About Cooley LLP

Clients partner with Cooley on transformative deals, complex IP and regulatory matters, and high-stakes litigation, where innovation meets the law.

Cooley has 900 lawyers across 12 offices in the United States, China and Europe.


Related Contacts
Div Gupta  Partner New York
Brian Leaf  Partner Reston
Brent Siler  Senior Counsel Washington, DC, Reston
Natasha Leskovsek  Of Counsel Washington, DC
Ivor Elrifi  Partner New York, Boston
Heidi A. Erlacher  Partner in Charge – Boston Boston
Francis Wheeler  Partner Colorado
Phil Mitchell  Partner New York
Madison Jones  Partner Washington, DC